Dimethyl sulfoxide (DMSO) 50% intravesical aqueous solution is manufactured by Mylan Pharmaceuticals with no other suppliers available. The current product on the market is expiring with an anticipated gap in therapy of 30 day until new product enters the market in November.
Newsroom
Immediate Practice Change Update
One of the global suppliers of heparin, China, has experienced active ingredient issues due to various reasons and this is expected to increase strain on other heparin suppliers.
As such, a proactive approach to conserving the stock we have in Northern Health is recommended.
There are three suppliers of hydroxyurea capsules in the Canadian marketplace.
The single source vendor for nystatin 100,000 units/g ointment is shorted and may be discontinuing the product. There is a small supply of the 30 gram tubes in Northern Health at this time.
The prolonged shortage of hyoscine 10 mg tablets has resolved.
All conservation strategies can be lifted and staff can resume regular use and prescribing.
Thank you to NH staff and physicians for your patience during this shortage.
The shortage of leucovorin 10 mg/mL X 50 mL vials is now resolved.
All conservation measures can be removed and staff can resume regular use and dosing.
Thank you to NH staff and physicians for your patience during this shortage.